VIVUS currently has two late stage clinical development programs in progress that target diabetes, and sleep apnea. Current research suggests that there is significant unmet need among patients living with these conditions.

Investigational Products Phase 1 Phase 2 Phase 3 NDA
Qsymia™ Sleep Apnea
Qsymia™ Diabetes